Enter your email address
Submit
Write your message
Volume 2, Issue 4 (Winter 2009)
IJT 2009, 2(4): 260-267 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kumar Dey S, Roy S. Effect of Chromium on Certain Aspects of Cellular Toxicity. IJT 2009; 2 (4) :260-267
URL: http://ijt.arakmu.ac.ir/article-1-62-en.html
URL: http://ijt.arakmu.ac.ir/article-1-62-en.html
1- Department of Bio-Medical Lab Science & Management Vidyasagar University, Midnapore West 2 Bengal, India , sankar_dey@yahoo.com
2- Department of Human pahysiology with Community Health, Vidyasagar University, Midnapore West Bengal, India
2- Department of Human pahysiology with Community Health, Vidyasagar University, Midnapore West Bengal, India
Abstract: (11648 Views)
Introduction: The impact of chromium exposure was studied on liver, kidney, testis, spleen, cerebrum and cerebellum of male Wistar rats (80-100 g body weight).
Material & Method: It was observed that treatments of rats with chromium (i.p. at a dose of 0.8 mg / 100 g body weight per day) for a period of 28 days caused significant increase in chromium content while declining the body weight along with the organ weight, except liver.
Results: Decreased acid phosphatase (ACP) and alkaline phosphatase (ALP) activities were observed in most of the organs. Significant increases in the cholesterol contents of all the organs were associated with the significant decreases in the level of phospholipids. Lipid peroxidation decreased in liver and kidney while it increased in testis, cerebrum and cerebellum. Reduced glutathione (GSH) level was found to be increased in liver, spleen and cerebrum, and decreased in kidney and testis. Catalase activity became elevated in liver, kidney, spleen and cerebellum while it decreased in testis.
Conclusion: It is suggested that chromium treatment at the present dose and duration induces general tissue toxicity by causing membrane damage due to changes in the relative proportion of cholesterol and phospholipids in the membrane structure. In addition, tissue specific toxicity is affected by lipid peroxidation in testis, cerebrum and cerebellum, and in other tissues increased GSH level or enhanced catalase activity prevents lipid peroxidation to occur due to reactive oxygen species produced from chromium transformation.
Material & Method: It was observed that treatments of rats with chromium (i.p. at a dose of 0.8 mg / 100 g body weight per day) for a period of 28 days caused significant increase in chromium content while declining the body weight along with the organ weight, except liver.
Results: Decreased acid phosphatase (ACP) and alkaline phosphatase (ALP) activities were observed in most of the organs. Significant increases in the cholesterol contents of all the organs were associated with the significant decreases in the level of phospholipids. Lipid peroxidation decreased in liver and kidney while it increased in testis, cerebrum and cerebellum. Reduced glutathione (GSH) level was found to be increased in liver, spleen and cerebrum, and decreased in kidney and testis. Catalase activity became elevated in liver, kidney, spleen and cerebellum while it decreased in testis.
Conclusion: It is suggested that chromium treatment at the present dose and duration induces general tissue toxicity by causing membrane damage due to changes in the relative proportion of cholesterol and phospholipids in the membrane structure. In addition, tissue specific toxicity is affected by lipid peroxidation in testis, cerebrum and cerebellum, and in other tissues increased GSH level or enhanced catalase activity prevents lipid peroxidation to occur due to reactive oxygen species produced from chromium transformation.
Keywords: Acid Phosphatase, Alkaline Phosphatase, Cholesterol, Chromium, Lipid, Peroxidation, Phospholipids, Reactive Oxygen Species
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
The Iranian Journal of Toxicology
Arak University of Medical Sciences in collaboration with the Iranian Society of Toxicology
Website: http://ijt.arakmu.ac.ir
Email: tox.journal@gmail.com
